Clinical Trial Update: NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for NRX-101 in complicated urinary tract infections including pyelonephritis is listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyelonephritis
• Urinary Tract Infection

Drugs mentioned

• NRX-101 (dextromethorphan/quinidine)

Snippet

Sponsor: NeuroRx, Inc. | Conditions: Urinary Tract Infections, Pyelonephritis | Phase 2 | Status: UNKNOWN